CHOP Study Finds CAR T-Cell Therapy Improves Survival Regardless of Socioeconomic Status
Nov 10, 2022
Researchers from Children’s Hospital of Philadelphia (CHOP) have found that economically disadvantaged children treated with CAR T-cell therapy for relapsed/refractory acute lymphoblastic leukemia (ALL) fair just as well as children from more socioeconomically advantaged backgrounds.